Rapid Micro Biosystems, Inc. (RPID)

NASDAQ: RPID · IEX Real-Time Price · USD
1.15
+0.02 (2.23%)
At close: Dec 7, 2023, 1:38 PM
1.14
-0.01 (-0.87%)
After-hours: Dec 7, 2023, 4:00 PM EST
2.23%
Market Cap 48.12M
Revenue (ttm) 20.56M
Net Income (ttm) -57.74M
Shares Out 37.09M
EPS (ttm) -1.34
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 53,853
Open 1.10
Previous Close 1.12
Day's Range 1.04 - 1.15
52-Week Range 0.83 - 1.89
Beta 1.30
Analysts Hold
Price Target 2.75 (+140.18%)
Earnings Date Nov 3, 2023

About RPID

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual micro... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 15, 2021
Employees 177
Stock Exchange NASDAQ
Ticker Symbol RPID
Full Company Profile

Financial Performance

In 2022, RPID's revenue was $17.13 million, a decrease of -26.25% compared to the previous year's $23.23 million. Losses were -$60.81 million, -22.08% less than in 2021.

Financial Statements

Analyst Forecast

According to one analyst, the rating for RPID stock is "Hold" and the 12-month stock price forecast is $2.75.

Price Target
$2.75
(140.18% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

4 weeks ago - GlobeNewsWire

Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results

Reports third quarter 2023 total revenue of $6.1 million , representing growth of 30% compared to third quarter 2022

4 weeks ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023

LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solut...

7 weeks ago - GlobeNewsWire

Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4

LOWELL, Mass., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

2 months ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase

LOWELL, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

2 months ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference

LOWELL, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

3 months ago - GlobeNewsWire

Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results

Reports second quarter 2023 total revenue of $5.0 million , representing growth of 30% compared to second quarter 2022

4 months ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023

LOWELL, Mass., July 20, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solut...

5 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors

LOWELL, Mass., July 18, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

5 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LOWELL, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation soluti...

7 months ago - GlobeNewsWire

Rapid Micro Biosystems Reports First Quarter 2023 Financial Results

Reports first quarter 2023 total revenue of $5.0 million , representing growth of 21% , compared to first quarter 2022

7 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing

LOWELL, Mass., May 04, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation soluti...

7 months ago - GlobeNewsWire

Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023

LOWELL, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

8 months ago - GlobeNewsWire

Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance

Reports fourth quarter 2022 commercial revenue of $4.4 million

9 months ago - GlobeNewsWire

Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference

LOWELL, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

10 months ago - GlobeNewsWire

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023

LOWELL, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

10 months ago - GlobeNewsWire

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue

Full year 2022 commercial revenue expected to be between $17.0 million and $17.2 million

11 months ago - GlobeNewsWire

Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference

LOWELL, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology

LOWELL, Mass., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company, providing mission critical automation solu...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems Concludes Review of Strategic Alternatives

LOWELL, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results

Reports third quarter 2022 commercial revenue of $4.7 million

1 year ago - GlobeNewsWire

Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System

LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference

LOWELL, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solut...

1 year ago - GlobeNewsWire

Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference

LOWELL, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solu...

1 year ago - GlobeNewsWire

Hill International, Rapid Micro Biosystems See Activist Investor Action

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities.

1 year ago - Market Watch